Korro Bio (KRRO) Stock: Buy, Sell, or Hold?
KRRO - Korro Bio, Inc. Common Stock
$11.98
-0.07 (-0.58%)
▼
5d:
+41.11%
30d:
+25.18%
90d:
+11.75%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 11, 2026
17d
Get Alerted When KRRO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: KRRO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: KRRO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: KRRO is currently trading at $11.98, which is considered extended relative to its 30-day fair value range of $8.83 to $11.50.
Technical Outlook: Technically, KRRO is in a downtrend. Immediate support is located at $8.34, while resistance sits at $12.49.
Market Sentiment: KRRO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.20 (+68.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KRRO is in a downtrend. Immediate support is located at $8.34, while resistance sits at $12.49.
Market Sentiment: KRRO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.20 (+68.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$8.83 -
$11.50
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
41.7%
Protect Your Profits
Holding KRRO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 68.6% below Wall St target ($20.20)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.83 -
$11.50
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.61
(13.4%)
Support & Resistance Levels
Support Level
$8.34
Resistance Level
$12.49
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.71
Wall Street Target
$20.20
(+68.6%)
Revenue Growth (YoY)
-43.1%
Share & Embed Analysis
Last updated: October 24, 2026 2:02 AM ET
Data refreshes hourly during market hours. Next update: 3:02 AM
Data refreshes hourly during market hours. Next update: 3:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KRRO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 64 BUY |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 35 SELL |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 65 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 61 BUY |
Advanced KRRO Option Strategies
Professional options setups generated by AI based on today's KRRO price and gamma walls.
